Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)

PHASE3CompletedINTERVENTIONAL
Enrollment

712

Participants

Timeline

Start Date

May 29, 2017

Primary Completion Date

April 18, 2025

Study Completion Date

April 18, 2025

Conditions
Carcinoma,Non-Small-Cell LungLung Carcinomas, Non-Small-CellNon-small-cell Lung CarcinomaNonsmall Cell Lung Cancer
Interventions
DRUG

Pemetrexed

Patients will be administered pemetrexed chemotherapy as per protocol with either cisplatin or carboplatin

DRUG

Paclitaxel

Patients will be administered paclitaxel chemotherapy as per protocol with either cisplatin or carboplatin

DRUG

Gemcitabine

Patients will be administered gemcitabine chemotherapy as per protocol with either cisplatin or carboplatin

DRUG

Cisplatin

Administered with either Pemetrexed, Paclitaxel or gemcitabine.

DRUG

Carboplatin

Administered with either Pemetrexed, Paclitaxel or gemcitabine.

DRUG

cemiplimab

Patients will be administered cemiplimab as per protocol.

Trial Locations (192)

Unknown

Clinical Study Site, Albury

Clinical Study Site, Wollongong

Clinical Study Site, Fitzroy

Clinical Study Site, Minsk

Clinical Study Site, Mogilev

Clinical Study Site 1, Porto Alegre

Clinical Study Site, Barretos

Clinical Study Site, Curitiba

Clinical Study Site, Joinville

Clinical Study Site, Lajeado

Clinical Study Site, Mogi das Cruzes

Clinical Study Site, Passo Fundo

Clinical Study Site, Pelotas

Clinical Study Site 2, Porto Alegre

Clinical Study Site 3, Porto Alegre

Clinical Study Site, Recife

Clinical Study Site, Rio de Janeiro

Clinical Study Site, Salvador

Clinical Study Site, Santa Cecília

Clinical Study Site, São José do Rio Preto

Clinical Study Site #3, São Paulo

Clinical Study Site #4, São Paulo

Clinical Study Site 1, São Paulo

Clinical Study Site 2, São Paulo

Clinical Study Site, Dobrich

Clinical Study Site, Gabrovo

Clinical Study Site, Recoleta

Clinical Study Site, Santiago

Clinical Study Site, Temuco

Clincial Study Site, Viña del Mar

Clinical Study Site, Lanshan

Clinical Study Site, Guangdong

Clinical Study Site, Harbin

Clinical Study Site, Linyi

Clinical Study Site 1, Shanghai

Clinical Study Site 2, Shanghai

Clinical Study Site 1, Tianjin

Clinical Study Site 2, Tianjin

Clinical Study Site, Xuzhou

Clinical Study Site, Zhejiang

Clinical Study Site, Barranquilla

Clinical Study Site, Bogotá

Clinical Study Site, Floridablanca

Clinical Study Site, Nový Jičín

Clinical Study Site, Pelhřimov

Clinical Study Site, Prague

Clinical Study Site, Batumi

Clinical Study Site #6, Tbilisi

Clinical Study Site 1, Tbilisi

Clinical Study Site 2, Tbilisi

Clinical Study Site 3, Tbilisi

Clinical Study Site 4, Tbilisi

Clinical Study Site 5, Tbilisi

Clinical Study Site, Pátrai

Clinical Study Site, Cholargós

Clinical Study Site 1, Athens

Clinical Study Site 2, Athens

Clinical Study Site 3, Athens

Clinical Study Site, Larissa

Clinical Study Site, Pylaia

Clinical Study Site 1, Thessaloniki

Clinical Study Site 2, Thessaloniki

Clinical Study Site 3, Thessaloniki

Clinical Study Site, Gyula

Clinical Study Site, Tatabánya

Clinical Study Site, Farkasgyepű

Clinical Study Site, Budapest

Clinical Study Site, Debrecen

Clinical Study Site, Zalaegerszeg

Clinical Study Site, Amman

Clinical Study Site, Irbid

Clinical Study Site, Bsalîm

Clinical Study Site, Mazraat ech Choûf

Clinical Study Site, Sidon

Clinical Study Site, Kampung Baharu Nilai

Clinical Study Site #1, Kuala Lumpur

Clinical Study Site #2, Kuala Lumpur

Clinical Study Site, Kuching

Clinical Study Site, Pulau Pinang

Clinical Study Site, Tanjong Bungah

Clinical Study Site, Coahuila

Clinical Study Site, Cuautitlán

Clinical Study Site, Jalisco

Clinical Study Site, León

Clinical Study Site 1, Monterrey

Clinical Study Site 2, Monterrey

Clinical Study Site 3, Monterrey

Clinical Study Site, Oaxaca City

Clinical Study Site, San Luis Potosí City

Clinical Study Site, Bacolod City

Clinical Study Site, Batangas

Clinical Study Site, Cebu

Clinical Study Site, City of Taguig

Clinical Study Site, Davao City

Clinical Study Site 1, Manila

Clinical Study Site 2, Manila

Clinical Study Site #1, Quezon City

Clinical Study Site #2, Quezon City

Clinical Study Site, Dąbrowa Górnicza

Clinical Study Site, Gdynia

Clinical Study Site, Krakow

Clinical Study Site, Lodz

Clinical Study Site, Olsztyn

Clinical Study Site, Poznan

Clinical Study Site, Prabuty

Clinical Study Site, Radom

Clinical Study Site, Rzeszów

Clinical Study Site, Torun

Clinical Study Site, Warsaw

Clinical Study Site, Wodzisław Śląski

Clinical Study Site 1, Craiova

Clinical Study Site 2, Craiova

Clinical Study Site, Floreşti

Clinical Study Site, Ploieşti

Clinical Study Site, Timișoara

Clinical Study Site, Ufa

Clinical Study Site, Pushkin

Clinical Study Site, Arkhangelsk

Clinical Study Site, Belgorod

Clinical Study Site, Chelyabinsk

Clinical Study Site, Kaluga

Clinical Study Site, Kazan'

Clinical Study Site, Kemerovo

Clinical Study Site, Kislino

Clinical Study Site, Kursk

Clinical Study Site 1, Moscow

Clinical Study Site 2, Moscow

Clinical Study Site 3, Moscow

Clinical Study Site, Omsk

Clinical Study Site, Pyatigorsk

Clinical Study Site 1, Saint Petersburg

Clinical Study Site 2, Saint Petersburg

Clinical Study Site 3, Saint Petersburg

Clinical Study Site 4, Saint Petersburg

Clinical Study Site, Samara

Clinical Study Site, Saransk

Clinical Study Site, Sochi

Clinical Study Site 1, Tomsk

Clinical Study Site 2, Tomsk

Clinical Study Site, Yekaterinburg

Clinical Study Site, Manresa

Clinical Study Site, Barcelona

Clinical Study Site, Pamplona

Clinical Study Site, Chang-hua

Clinical Study Site, Hualien City

Clinical Study Site 1, Kaohsiung City

Clinical Study Site 2, Kaohsiung City

Clinical Study Site 1, New Taipei City

Clinical Study Site 2, New Taipei City

Clinical Study Site 1, Taichung

Clinical Study Site 2, Taichung

Clinical Study Site 1, Taipei

Clinical Study Site 2, Taipei

Clinical Study Site 3, Taipei

Clinical Study Site, Hat Yai

Clinical Study Site, Lopburi

Clinical Study Site #1, Bangkok

Clinical Study Site #2, Bangkok

Clinical Study Site, Chiang Rai

Clinical Study Site, Khon Kaen

Clinical Study Site, Lampang

Clinical Study Site, Phitsanulok

Clinical Study Site, Ratchathewi

Clinical Study Site, Udon Thani

Clinical Study Site 1, Adana

Clinical Study Site 2, Adana

Clinical Study Site 1, Ankara

Clinical Study Site 2, Ankara

Clinical Study Site 3, Ankara

Clinical Study Site 4, Ankara

Clinical Study Site 5, Ankara

Clinical Study Site, Edirne

Clinical Study Site 1, Istanbul

Clinical Study Site 2, Istanbul

Clinical Study Site 3, Istanbul

Clinical Study Site 4, Istanbul

Clinical Study Site 1, Izmir

Clinical Study Site 2, Izmir

Clinical Study Site 3, Izmir

Clinical Study Site, Samsun

Clinical Study Site, Dnipro

Clinical Study Site, Ivano-Frankivsk

Clinical Study Site, Kharkiv

Clinical Study Site, Kherson

Clinical Study Site 1, Kiev

Clinical Study Site 2, Kiev

Clinical Study Site, Kirovohrad

Clinical Study Site 1, Kyiv

Clinical Study Site 2, Kyiv

Clinical Study Site, Uzhhorod

Clinical Study Site, Vinnytsia

Clinical Study Site, Zaporizhzhya

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY